Ray Dalio Abiomed Inc Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$242.49 - $301.46 $521,838 - $648,741	2,152 Added 2.39%	92,377 $22.7 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $5.25 Million - $7.91 Million	23,353 Added 34.92%	90,225 $22.3 Million
Q1 2022 May 13, 2022	BUY	$277.25 - $366.29 $4.96 Million - $6.55 Million	17,874 Added 36.48%	66,872 $22.2 Million
Q4 2021 Feb 14, 2022	BUY	$300.63 - $371.35 $736,844 - $910,178	2,451 Added 5.27%	48,998 $17.6 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $736,391 - $893,098	-2,374 Reduced 4.85%	46,547 $15.2 Million
Q2 2021 Aug 13, 2021	BUY	$262.71 - $351.17 $4.71 Million - $6.29 Million	17,920 Added 57.8%	48,921 $15.3 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $1.45 Million - $1.81 Million	5,084 Added 19.62%	31,001 $9.88 Million
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $3.84 Million - $4.94 Million	15,226 Added 142.42%	25,917 $8.4 Million
Q3 2020 Nov 13, 2020	BUY	$255.22 - $317.0 $2.73 Million - $3.39 Million	10,691 New	10,691 $2.96 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.